Patient characteristics, tumour stage and treatment
| Carcinoid | NSCLC | |
|---|---|---|
| N | 1341 | 161 618 |
| Patient characteristics | ||
| Age—mean (SD) | 62 (15) | 72 (11) |
| Female | 62% | 44% |
| Performance status 0–1 | 91.4% | 52.6% |
| FEV1—mean (SD) | 2.27 (0.83) | 1.71 (0.72) |
| Stage | ||
| Localised | 65.7% | 20.4% |
| Regional | 6.3% | 22.3% |
| Metastatic | 8.7% | 43.1% |
| Unknown | 19.2% | 14.2% |
| Treatment | ||
| Surgery | 76.9% | 14.2% |
| Chemotherapy | 6.2% | 25.7% |
| Radiotherapy | 3.6% | 28.4% |
| No treatment recorded | 13.3% | 31.7% |
FEV1, forced expiratory volume in 1 s; NSCLC, non-small cell lung cancer.